85 related articles for article (PubMed ID: 9816260)
1. Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered response in accumulation-defective resistant cells.
Marverti G; Andrews PA
Clin Cancer Res; 1996 Jun; 2(6):991-9. PubMed ID: 9816260
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.
Andrews PA; Albright KD
Cancer Res; 1992 Apr; 52(7):1895-901. PubMed ID: 1551118
[TBL] [Abstract][Full Text] [Related]
3. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
4. Modulation of methotrexate resistance by genistein in murine leukemia L1210 cells.
Xuan Y; Hacker MP; Tritton TR; Bhushan A
Oncol Rep; 1998; 5(2):419-21. PubMed ID: 9468571
[TBL] [Abstract][Full Text] [Related]
5. Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance.
Zinkewich-Péotti K; Andrews PA
Cancer Res; 1992 Apr; 52(7):1902-6. PubMed ID: 1551119
[TBL] [Abstract][Full Text] [Related]
6. cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
Andrews PA; Velury S; Mann SC; Howell SB
Cancer Res; 1988 Jan; 48(1):68-73. PubMed ID: 3335000
[TBL] [Abstract][Full Text] [Related]
7. Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro.
Jekunen A; Vick J; Sanga R; Chan TC; Howell SB
Cancer Res; 1992 Jul; 52(13):3566-71. PubMed ID: 1617625
[TBL] [Abstract][Full Text] [Related]
8. Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells.
Andrews PA; Mann SC; Huynh HH; Albright KD
Cancer Res; 1991 Jul; 51(14):3677-81. PubMed ID: 1648442
[TBL] [Abstract][Full Text] [Related]
9. Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.
Mann SC; Andrews PA; Howell SB
Anticancer Res; 1988; 8(6):1211-5. PubMed ID: 3218956
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant.
Chau Q; Stewart DJ
Cancer Chemother Pharmacol; 1999; 44(3):193-202. PubMed ID: 10453720
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells.
Lei W; Mayotte JE; Levitt ML
Anticancer Res; 1999; 19(1A):221-8. PubMed ID: 10226546
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
Samimi G; Howell SB
Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the human bradykinin B2 receptor expressed in sf21 insect cells: a possible role for tyrosine kinases.
Reyes-Cruz G; Vázquez-Prado J; Müller-Esterl W; Vaca L
J Cell Biochem; 2000 Jan; 76(4):658-73. PubMed ID: 10653985
[TBL] [Abstract][Full Text] [Related]
14. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.
Waud WR
Cancer Res; 1987 Dec; 47(24 Pt 1):6549-55. PubMed ID: 3677093
[TBL] [Abstract][Full Text] [Related]
15. Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle.
Cappelletti V; Fioravanti L; Miodini P; Di Fronzo G
J Cell Biochem; 2000 Sep; 79(4):594-600. PubMed ID: 10996850
[TBL] [Abstract][Full Text] [Related]
16. Secretin regulates paracellular permeability in canine gastric monolayers by a Src kinase-dependent pathway.
Chen MC; Solomon TE; Perez Salazar E; Kui R; Rozengurt E; Soll AH
Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G893-9. PubMed ID: 12223349
[TBL] [Abstract][Full Text] [Related]
17. Effect of intracellular chloride on the cellular pharmacodynamics of cis-diamminedichloroplatinum(II).
Jennerwein M; Andrews PA
Drug Metab Dispos; 1995 Feb; 23(2):178-84. PubMed ID: 7736908
[TBL] [Abstract][Full Text] [Related]
18. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
[TBL] [Abstract][Full Text] [Related]
19. Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell line.
Naredi P; Heath DD; Enns RE; Howell SB
Cancer Res; 1994 Dec; 54(24):6464-8. PubMed ID: 7987844
[TBL] [Abstract][Full Text] [Related]
20. In vitro modulating effect of the reversible protein synthesis inhibitor zilascorb (2H) on cis-diamminedichloroplatinum (II)-induced cytotoxicity.
Melvik JE; Dornish JM; Larsen RO; Børretzen B; Oftebro R; Pettersen EO
Anticancer Res; 1992; 12(1):33-8. PubMed ID: 1567178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
